BCL2 and cancer: We also demonstrate that pharmacological manipulation of Bcl-2 family proteins or DDR kinases enhances the cell-killing effects of anti-mitotic drugs on proliferating cancer cells by enhancing the response to mitotic stress, providing a rationale for combination chemotherapy.